High PDLIM2 expression levels were associated with a shorter DFI in KIRP (P = 0.023), prostate adenocarcinoma (P = 0.026), and ovarian serous cystadenocarcinoma (P = 0.012) (Fig. 3e–g). The gene discussed is PDLIM2; the disease is ovarian serous cystadenocarcinoma.